HAND2 and endometrial carcinoma: Thus, for the lncRNA HAND2-AS1, inactivating gene hypermethylation, tumor suppressor activity, and the ability to increase sensitivity to antitumor therapy were shown in EOC cells [22,30], and ability to suppress invasion was demonstrated in endometrial carcinoma [31].